Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 9c
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.53), $0.09 better than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: BlackBerry (BB) Reports In-Line Q1 EPS
- Rite Aid (RAD) Tops Q1 EPS by 16c, FY EPS Guidance Misses Consensus
- Accenture (ACN) Tops Q3 EPS by 17c, Updates FY Guidance
Create E-mail Alert Related CategoriesEarnings, Guidance
Related EntitiesThe Children's Investment Fund (TCI), Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!